tiprankstipranks
Trending News
More News >
Purple Biotech Ltd. (IL:PPBT)
:PPBT
Israel Market
Advertisement

Purple Biotech (PPBT) Price & Analysis

Compare
0 Followers

PPBT Stock Chart & Stats


Financials

PPBT FAQ

What was Purple Biotech Ltd.’s price range in the past 12 months?
Purple Biotech Ltd. lowest stock price was 3.90 and its highest was 21.00 in the past 12 months.
    What is Purple Biotech Ltd.’s market cap?
    Purple Biotech Ltd.’s market cap is 24.99M.
      When is Purple Biotech Ltd.’s upcoming earnings report date?
      Purple Biotech Ltd.’s upcoming earnings report date is Aug 14, 2025 which is in 19 days.
        How were Purple Biotech Ltd.’s earnings last quarter?
        Purple Biotech Ltd. released its earnings results on May 21, 2025. The company reported -0.3 earnings per share for the quarter, missing the consensus estimate of N/A by -0.3.
          Is Purple Biotech Ltd. overvalued?
          According to Wall Street analysts Purple Biotech Ltd.’s price is currently Overvalued. Get more investment ideas with TipRanks Premium
            Does Purple Biotech Ltd. pay dividends?
            Purple Biotech Ltd. pays a Notavailable dividend of 249.549 which represents an annual dividend yield of N/A. See more information on Purple Biotech Ltd. dividends here
              What is Purple Biotech Ltd.’s EPS estimate?
              Purple Biotech Ltd.’s EPS estimate for its next earnings report is not yet available.
              How many shares outstanding does Purple Biotech Ltd. have?
              Purple Biotech Ltd. has 567,961,800 shares outstanding.
                What happened to Purple Biotech Ltd.’s price movement after its last earnings report?
                Purple Biotech Ltd. reported an EPS of -0.3 in its last earnings report, missing expectations of N/A. Following the earnings report the stock price went up 4.878%.
                  Which hedge fund is a major shareholder of Purple Biotech Ltd.?
                  Currently, no hedge funds are holding shares in IL:PPBT

                  Company Description

                  Purple Biotech Ltd.

                  Purple Biotech Ltd. (NASDAQ: PPBT) is a clinical-stage pharmaceutical company focused on developing innovative therapies that target cancer and other chronic diseases. The company specializes in oncology and immunology, leveraging its proprietary drug discovery platforms to advance a pipeline of novel drug candidates. Purple Biotech aims to address unmet medical needs through its research and development efforts, with a commitment to improving patient outcomes and enhancing the quality of life for individuals battling severe illnesses.
                  Similar Stocks
                  Company
                  Price & Change
                  Follow
                  Brainsway
                  Teva
                  Can Fite Bio
                  Popular Stocks
                  What am I Missing?
                  Make informed decisions based on Top Analysts' activity
                  Know what industry insiders are buying
                  Get actionable alerts from top Wall Street Analysts
                  Find out before anyone else which stock is going to shoot up
                  Get powerful stock screeners & detailed portfolio analysis